文献速递冠心病

超声斑块衰减与低回声进展与主要不良心血管事件相关

Progression of ultrasound plaque attenuation and low echogenicity associates with major adverse cardiovascular events.
PubMed 文献 · Eur Heart J · 2020-01-01

该研究基于两项临床试验的1497例冠心病患者连续血管内超声影像,随访18-24个月,评估衰减斑块(AP)和低回声斑块(ELP)与主要不良心血管事件(MACE)的关系。结果显示AP/ELP进展与MACE风险升高独立相关(HR 2.19,95%CI 1.24-3.86),支持识别高危易损斑块对冠心病患者风险分层的潜在价值。

要点

  • 基线AP/ELP阳性者MACE发生率高于阴性者(8.2% vs 3.9%,P=0.002)。
  • AP/ELP进展与MACE独立相关(HR 2.19,95%CI 1.24-3.86)。
  • AP/ELP进展者更常见急性冠脉综合征且基线斑块负荷更高。

核心结论

  • 衰减斑块或低回声斑块的进展与冠心病患者心血管事件发生率升高相关。
  • 识别高危易损斑块可能有助于冠心病患者的风险分层。

研究设计与样本

  • 对两项临床试验中1497例冠心病患者的连续血管内超声影像进行回顾性分析,随访18-24个月。
  • 计算衰减斑块指数(API)和低回声斑块体积,定义API或ELP体积任何增加为进展。
  • 主要心血管事件(MACE)包括死亡、心肌梗死、卒中和冠状动脉血运重建。

主要发现

  • 基线时282例(18.8%)存在AP或ELP,随访时160例(10.7%)出现AP或ELP增加。
  • 基线AP/ELP阳性者MACE发生率为8.2%,阴性者为3.9%(P=0.002)。
  • AP/ELP进展者中急性冠脉综合征比例更高(41.9% vs 33.2%,P=0.03),基线斑块体积百分比更大(40.0% vs 35.8%,P<0.001)。
  • 多变量分析显示基线AP/ELP与MACE相关(HR 1.76,95%CI 1.05-2.97),AP/ELP进展与MACE关联更强(HR 2.19,95%CI 1.24-3.86)。

临床怎么用

  • 在冠心病患者中,可通过血管内超声识别衰减斑块和低回声斑块,并监测其进展以辅助风险评估。
  • 基线存在AP/ELP或随访中出现进展的患者可能需更密切的临床关注。

局限性

  • 研究为对两项临床试验影像的回顾性分析,结果需前瞻性验证。
  • AP/ELP进展的定义基于API或ELP体积的任何增加,未报告阈值依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Intravascular ultrasound (IVUS) imaging can visualize vulnerable plaque features including attenuation (AP) and echolucency (ELP). While IVUS-derived vulnerable plaque features associate with microvascular obstruction during percutaneous coronary intervention, the relationship between these plaque features and clinical outcomes has not been established. This analysis aimed to evaluate the association of AP/ELP with cardiovascular events. METHODS AND RESULTS: Serial IVUS imaging was reviewed in 1497 patients, followed for 18-24 months, with coronary artery disease from two clinical trials. Attenuated plaque and ELP were identified to measure each characteristics (AP arc, ELP area, and lengths), which permitted calculation of an AP index (API) and ELP volume. Attenuated plaque/ELP progression was defined as patients with any increase of API or ELP volume on serial imaging. The major cardiovascular events (MACEs) were defined as death, myocardial infarction, stroke, and coronary revascularization. AP or ELP was identified in 282 patients (18.8%) at baseline and 160 (10.7%) patients demonstrated an increase in AP or ELP at follow-up. The incidence of MACE was higher in patients with baseline AP/ELP than those without (8.2% vs. 3.9%, P = 0.002). Patients with AP/ELP progression were more likely to be acute coronary syndrome (41.9 vs. 33.2%, P = 0.03) and have greater baseline percent atheroma volume (40.0% vs. 35.8%, P < 0.001) than those without. On multivariable analysis, AP/ELP progression was more strongly associated with MACE [baseline AP/ELP: hazard ratio (HR) 1.76, 95% confidence interval (CI) 1.05-2.97, AP/ELP progression: HR 2.19, 95% CI 1.24-3.86]. CONCLUSION: Attenuation/ELP progression was associated with a higher prevalence of cardiovascular events, supporting a potential role for the identification of high-risk vulnerable plaques in patients with coronary artery disease.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Shishikura D, Kataoka Y, Di Giovanni G, et al. Progression of ultrasound plaque attenuation and low echogenicity associates with major adverse cardiovascular events. Eur Heart J. 2020. PMID: 32243512. doi:10.1093/eurheartj/ehaa173

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。